Senior insider sale
Pres &Chief Investment Officer at ROIVANT SCIENCES LTD. — senior position signals high conviction
$7.40M
338.70K shares
What this filing means
SUKHATME MAYUKH plans to sell 338.70K shares of ROIVANT SCIENCES LTD. valued at approximately $7.40M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/29/2025ACC: 0001965301-25-000191
Officer· Pres &Chief Investment Officer
Since Oct 2021
338.70K
Shares to sell
$7.40M
Approx. market value
311.87K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months2
Options Grant - 3/26/2020
wire
12/29/2025
155.94KOptions Grant - 03/26/2020
wire
12/29/2025
155.94KTotal acquired311.87K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/29/2025 | Options Grant - 3/26/2020 wire | 155.94K | — |
12/29/2025 | Options Grant - 03/26/2020 wire | 155.94K | — |
| Total | 311.87K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
26.83K
Market value
$619.5K
12/17/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
311.87K
Market value
$6.78M
12/29/2025
Total
Units
338.70K
Value
$7.40M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
12/17/2025 | 26.83K | $619.5K | — | Completed |
| Planned — Approximate Date | ||||
12/29/2025 | 311.87K | $6.78M | NASDAQ | Planned |
| Total | 338.70K | $7.40M | ||